Veloxis’ VEL-101 Granted FDA Orphan Drug Designati...
Category : ODD/BTA/FTA Status 22 January 2026Veloxis Pharmaceuticals, Inc., a global specialty pharmaceutical company and part of Asahi Kasei Cor...
Odd Bta Fta Status
Ionis Pharmaceuticals Secures FDA Breakthrough The...
Category : ODD/BTA/FTA Status 5 December 2025Ionis Pharmaceuticals has achieved a major regulatory milestone with the U.S. FDA granting Breakthro...
FDA Grants Fast Track Status to VS-041, a Novel MM...
Category : ODD/BTA/FTA Status 19 November 2025Vasa Therapeutics has received FDA Fast Track designation for VS-041, its lead investigational small...
FDA Grants Orphan Drug Designation to Calico and A...
Category : ODD/BTA/FTA Status 6 November 2025California, October 2025: Calico Life Sciences LLC (Calico), a biotechnology company founded by Alph...
Halia Therapeutics Receives FDA Orphan Drug Design...
Category : ODD/BTA/FTA Status 25 October 2025Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on therapies that targe...
Latest Newsletter Post
-
AstraZeneca Signs $18.5 Billion Lic..
3 February 2026
-
Japan Leads Asia in FDA Novel Drug..
3 February 2026
-
Mwyngil Therapeutics Initiates Phas..
3 February 2026
-
Crystalys Doses First Patients in E..
3 February 2026
-
Almirall’s Seysara receives China N..
2 February 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com